Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DNA methylation aging changes in MSC therapy
jRCT1010220030Recruiting
- Sponsor
- Masanori Sasaki
- Start
- Dec 2022
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of Stemirac in traumatic brain injury (TBI), sponsored by Masanori Sasaki. Primary endpoint: DNAge (DNAge Epigenetic Aging Clock). Started Dec 2022; status: recruiting.
02
Drugs
Stemirac
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on jRCT1010220030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1010220030.